Skip to content
          • Log In
      Drug Discovery World (DDW)Drug Discovery World (DDW)
        • About Us
        • Subscribe Free
        • Media Info
        • Contact Us
          Drug Discovery World (DDW) Menu   ≡ ╳
          • Home
          • News
          • Exclusive Content
            • Features
            • Opinion
            • Market Reports
            • Trends & Analysis
            • Start-up Zone
          • DDW eBooks & eReports
          • Cancer Research
          • Business
          • Regulatory
          • Events
          • Webinars
          • Resources
          • Magazine
            • Digital Issues
            • Archive
          • Multimedia
            • Videos
            • Podcasts

          Sidebar Banner 6

          Sidebar Banner 7

          Sidebar Banner 8

          Sidebar Banner 12

          Sidebar Banner 18

          Sidebar Banner 19

          Sidebar Banner 20

          Sidebar Banner 21

        Nanobodies

        Examining a sample under the microscope

        Novel nanobody technology boosts thrombosis research

        18 October 2023

        Researchers from the Institute of Cardiovascular Sciences at the University of Birmingham, UK, have produced the first binding molecules (ligands) of defined composition to make platelets clump together in a predictable way. The research team, led by Professor Steve Watson and Dr Eleyna Martin, developed antibody fragments called nanobodies and crosslinked these to make ligands […]

        Can llama antibodies help develop a Covid-19 therapy?

        8 December 2021

        Amid the growing threat of a new and potentially more dangerous SARS-CoV-2 variant, scientists are ramping up the quest for Covid treatments. A recent study demonstrates the therapeutic potential of an unusual class of immune proteins: miniature antibodies called nanobodies, derived from llamas. Rockefeller University scientists Michael P. Rout and Brian T. Chait and their colleagues at the Seattle […]

        ChromoTek and Absolute Antibody collaborate on recombinant antibodies

        26 February 2021

        ChromoTek, part of Proteintech specialising in nanobody-based reagents, and Absolute Antibody, provider of recombinant antibody technology, have announced a partnership to offer recombinant engineered antibodies to scientists worldwide. The chimeric antibodies were originally derived from alpaca nanobodies and engineered onto mouse and rabbit Fc domains to open up new research applications. Available antibodies target key […]

        Sidebar Banner 1

        Sidebar Banner 2

        Sidebar Banner 3

        Sidebar Banner 4

        Sidebar Banner 9

        Sidebar Banner 10

        Sidebar Banner 11

        Sidebar Banner 13

        Sidebar Banner 14

        Sidebar Banner 15

        Sidebar Banner 16

        Sidebar Banner 17

          • Contact Us
          • About Us
          • Subscribe FREE
          • Media Info
          • Log In
          • Terms and Conditions
          • Privacy Policy
          • Cookie Policy

        Follow our social accounts

             

        Copyright 2023 © Drug Discovery World (DDW). All Rights Reserved

        Designed & Developed with ❤ for digital by Inbound FinTech

        • Home
        • News
        • Exclusive Content
          • Features
          • Market Reports
          • Opinion
          • Trends & Analysis
          • Start-up Zone
        • DDW eBooks & eReports
        • Cancer Research
        • Business
        • Regulatory
        • Events
        • Webinars
        • Resources
        • Magazine
          • Digital Issues
          • Archive
        • Multimedia
          • Podcasts
          • Videos
        • About Us
        • Subscribe Free
        • Media Info
        • Contact Us
            • Log In